CoreLine Soft Co

CoreLine Soft Co SG&A Expenses

The Selling, General & Administrative Expenses of CoreLine Soft Co (384470.KQ) as of Nov 11, 2026 is 5.71 B KRW. In the previous year, Selling, General & Administrative Expenses was 13.41 B KRW — a change of -57.43% (lower).

SG&A Expenses

5.71 BKRW

YoY

-57.43%

Last updated:

Selling, General & Administrative Expenses of CoreLine Soft Co is 2025 5.71 B KRW. Selling, General & Administrative Expenses of CoreLine Soft Co was 2024 13.41 B KRW. It decreases by -57.43% lower compared to the previous year.

The CoreLine Soft Co SG&A Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

SG&A Expenses
Date
SG&A Expenses
Jan 1, 2020
4.19 B KRW
Jan 1, 2021
3.54 B KRW
Jan 1, 2022
10.43 B KRW
Jan 1, 2023
12.10 B KRW
Jan 1, 2024
13.41 B KRW
Jan 1, 2025
5.71 B KRW
The CoreLine Soft Co SG&A Expenses history
YEARSG&A ExpensesYoY
5.71 BKRW-57.43%
13.41 BKRW+10.76%
12.10 BKRW+16.01%
10.43 BKRW+194.99%
3.54 BKRW-15.49%
4.19 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CoreLine Soft Co Stock analysis

What does CoreLine Soft Co do? CoreLine Soft Co Ltd develops and supplies AI-based medical image analysis software for healthcare professionals. The company's main products analyze CT images of the chest, head, and neck to assist in diagnosis and support treatment and research. The firm targets medical staff in hospitals and research institutions who require advanced diagnostic tools. CoreLine Soft generates revenue through the sale of its medical software solutions to healthcare providers and research organizations. The company operates in the Health Care Technology industry with a focus on AI-driven medical imaging. CoreLine Soft's products are designed to enhance diagnostic accuracy and streamline treatment planning for medical professionals. Revenue is derived from licensing agreements with healthcare facilities and research entities that integrate the software into their diagnostic workflows. CoreLine Soft Co Ltd is a Korea-based company headquartered in Seoul. The firm's primary business model revolves around the development and commercialization of AI-based medical software. The company's revenue streams come from direct sales of its CT image analysis solutions to hospitals and research institutions seeking to improve diagnostic efficiency and patient outcomes. CoreLine Soft Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CoreLine Soft Co stock

Selling, General & Administrative Expenses of CoreLine Soft Co is 5.71 B KRW in 2025.

Selling, General & Administrative Expenses of CoreLine Soft Co changed from 13.41 B KRW to 5.71 B KRW, representing a -57.43% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Selling, General & Administrative Expenses CoreLine Soft Co since 2006 – with annual values, charts, and detailed analysis.

SG&A expenses include all non-production costs such as salaries, marketing, rent, and administrative overhead. They are a key component of operating expenses.

Selling, General & Administrative Expenses's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Selling, General & Administrative Expenses's CoreLine Soft Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — CoreLine Soft Co

All Key Metrics — CoreLine Soft Co